Navigation Links
CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
Date:11/21/2008

MAIDENHEAD, England, November 21 /PRNewswire-FirstCall/ --

- Not for UK Journalists

The European Committee for Medicinal Products for Human Use (CHMP) today announced its positive recommendation for the approval of Enbrel(R) (etanercept) as a treatment for children aged 8 years and over and adolescents with severe plaque psoriasis. If approved by the European Commission, following the Committee's recommendation, Enbrel will become the first biologic treatment indicated for severe psoriasis in children and adolescents. Enbrel is currently approved in the European Union for the treatment of moderate-to-severe plaque psoriasis in adults, as well as for ankylosing spondylitis, psoriatic arthritis, moderate to severe rheumatoid arthritis (RA) in adults, and polyarticular juvenile idiopathic arthritis (JIA) in children.(1)

"Psoriasis can be a distressing disease at any age," said Stevo Knezevic, MD, PhD, Chief Medical Officer of Wyeth Europa. "A third of psoriasis patients first see signs of the disease well before the age of 16 and there are currently limited effective treatment options available with approved dosing regimens for children and adolescents. We are, therefore, encouraged by the positive recommendation from the CHMP for the approval of Enbrel(R) for use in the paediatric population."

The recommendation by the CHMP is based on results from the first randomised placebo-controlled trial of a biologic treatment in children aged 17 and under (study 211). Results from the study showed that patients treated with Enbrel experienced a significant improvement of their plaque psoriasis compared to those treated with placebo. There were no serious adverse events or serious infections during the 12-week placebo-controlled period and rates of adverse events were similar for Enbrel and placebo.

Impact of Psoriasis

Across Europe, 5.1 million people are estimated to h
'/>"/>

SOURCE Wyeth Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Task Force Recommends Screening for Hearing Loss in All Newborns
2. FDA Advisory Committee Unanimously Recommends Approval of Ustekinumab for Treatment of Moderate to Severe Plaque Psoriasis
3. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
4. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
5. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
6. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
7. Berlin Hearts EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
10. Sunshine Heart Announces IDE Approval To Begin C-Pulse U.S. Clinical Feasibility Trial
11. Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 14, 2014  GenSpera, Inc. (OTCQB: GNSZ), a ... of cancer, announces that Kareg Corporation,s Director of ... the following research report on  the company. ... of Research, Kareg Corporation, Initiating Coverage with a ... full report: http://www.genspera.com/press/140711_Genspera_research_report_July2014.pdf GNSZ ...
(Date:7/14/2014)... 2014  Otonomy, Inc., a clinical-stage biopharmaceutical company focused ... diseases and disorders of the inner and middle ear, ... statement on Form S-1 with the U.S. Securities and ... offering of shares of its common stock. All shares ... will be offered by Otonomy. The number of shares ...
(Date:7/14/2014)... and LONDON , July 14, 2014 ... IXICO plc (AIM: IXI) jointly announced today the formation ... companies. Dr. Edward Ashton , Ph.D., chief scientific ... have seven members. "The formation of this ... the international commercial and operational alliance we signed with ...
Breaking Medicine Technology:Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 2Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 3Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 4Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 5Kareg Corporation Initiates Coverage on GenSpera with a Speculative Buy Recommendation 6Otonomy Files Registration Statement for Proposed Initial Public Offering 2VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 2VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 3VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 4VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 5VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 6VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 7VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 8VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 9
... YORK, Sept. 21 An eminent international panel of ... LLY ) to receive a World Business and ... successful partnerships in the battle against multidrug-resistant tuberculosis (MDR-TB). ... of The Lilly MDR-TB Partnership demonstrate a clear linkage ...
... According to Millennium Research Group (MRG), the global authority ... new growth factors, combined with greater variety and improved features ... market to nearly $2.3 billion through 2015. Medtronic ... AMPLIFY , is set to be released in the US ...
Cached Medicine Technology:Lilly Recognized with World Business and Development Award for Tuberculosis Initiative 2Lilly Recognized with World Business and Development Award for Tuberculosis Initiative 3Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015 2Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015 3
(Date:7/14/2014)... Laurel, N.J. (PRWEB) July 14, 2014 ... Mount Laurel, has announced the publication of its first military ... plane crash on Black Thursday in October 1943 and 19 ... March to return home and build the American dream. ... II and the American dream (Amazon) is a ...
(Date:7/14/2014)... According to a recent study ... a connection between women with high levels of a ... doctors have theorized about the role stress plays in ... provide scientific support. , “Stress, if very significant, can ... Barmat, an OB/GYN who specializes in reproductive endocrinology and ...
(Date:7/14/2014)... There’s an old adage that says first impressions make ... say the products offered in their preorder event not only ... The Lash Palette for $40,” said Jenelle Paris, founder and ... explained that the first 1,000 have already been sold during ... on to point out that her company is an online ...
(Date:7/14/2014)... Jordan Valley Medical Center is expanding the ... center set to open by the fall of 2015. ... west of I-15 in the Salt Lake Valley providing ... Valley Medical Center has partnered with Elekta, a company ... for radiation therapy, radiosurgery and brachytherapy, to bring Versa ...
(Date:7/14/2014)... For the Spanish Royal Academy, senescent is he who ... the dictionary: not only is senescence not a synonym ... the organism. Cellular senescence is such a badly named ... area think it needs another name. That is the ... Research Centre (CNIO), one of the world,s leading experts ...
Breaking Medicine News(10 mins):Health News:Mount Laurel-based Documented Legacy to Release Military Memoir of World War II Air Force Vet Who Survived Black Thursday Crash 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:The Lash Palette Preorder Event Has Officially Begun 2Health News:Jordan Valley Medical Center Set to Break Ground with New $10 Million Cancer Center 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 3
... diabetes research in India, even though the country remains one ... disease. Indian scientists have published only one percent of the ... Indian Journal of Medical Research, in an assessment of the ... India published a total of 3068 papers during the 30 ...
... 25 million dollar space programme, will carry out scientific ... cells in outer space, reports said Wednesday. ... and the crystallisation of protein, said Abdul Rahman Abdul ... National University of Malaysia. ,"The research is ...
... their health by using over the counter nutritional supplements ... cons with the health professionals managing their conventional treatment. ... Griffith's School of Nursing, says that though some complementary ... have side effects or interact with conventional medications. ...
... School of Medicine in St. Louis, Missouri, have found ... to treatments for deadliest poisons like Ricin, cholera toxin, ... deadly strains of E. coli bacteria, these toxins travel ... Golgi network and endoplasmic reticulum before interrupting protein synthesis. ...
... a developing female sheep foetus to low doses of commonly ... ,The study was conducted by a team ... of Aberdeen, Scotland, UK. ,As part of the ... a cocktail of chemicals and heavy metals in an animal ...
... New research by the British charity Save the Children, shows ... nutritious diet , they would have to spend three times ... reported by The Independent, this would amount to a 1,700 ... research calculated how much a healthy diet, based on local ...
Cached Medicine News:Health News:India's Share in Global Diabetes Research is One Percent 2Health News:Diabetics Risking Health by Using Alternative Medications Without Consultation 2Health News:For Bangladeshis, a Nutritious Diet Would Cost 1,700 Pounds Per Week 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: